Andy Merritt

1.3k citations

32 papers · 816 indexed · h-index 15

Co-authors: Duncan B. Judd John Brown Peter N. Lowe Guizhu Hong Liang Ye Andrew Lockhart Antony D. Gee Kristian Birchall
Topics: Computational Drug Discovery Methods (10 papers)Microbial Natural Products and Biosynthesis (4 papers)Asymmetric Synthesis and Catalysis (3 papers)
Cited by: Computational Theory and Mathematics Organic Chemistry Molecular Biology
Journals: Journal of Biological Chemistry The Journal of Organic Chemistry Frontiers in Immunology
Partner nations: United Kingdom United States Germany

In The Last Decade

Andy Merritt

30 papers receiving 798 citations

Peers

Countries citing papers authored by Andy Merritt

Since Specialization

Citations

This map shows the geographic impact of Andy Merritt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andy Merritt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andy Merritt more than expected).

Fields of papers citing papers by Andy Merritt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andy Merritt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andy Merritt. The network helps show where Andy Merritt may publish in the future.

Co-authorship network of co-authors of Andy Merritt

This figure shows the co-authorship network connecting the top 25 collaborators of Andy Merritt. A scholar is included among the top collaborators of Andy Merritt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andy Merritt. Andy Merritt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Formation of mono- and dual-labelled antibody fragment conjugates via reversible site-selective disulfide modification and proximity induced lysine reactivity 2025 ·Chemical Science ·(unknown),Nathalie Bouloc,(unknown),Ning Wang,Péter A. Szijj,(unknown),(unknown),(unknown),Andy Merritt,James R. Baker,Vijay Chudasama	1
2	Optimising digital twin laboratories with conversational AIs: enhancing immersive training and simulation through virtual reality 2025 ·Digital Discovery ·(unknown),Zaid Muwaffak,(unknown),(unknown),Steven R. Brown,Andy Merritt,Stephen T. Hilton	3
3	Identification and characterisation of anti-IL-13 inhibitory single domain antibodies provides new insights into receptor selectivity and attractive opportunities for drug discovery 2023 ·Frontiers in Immunology ·(unknown),(unknown),(unknown),Jacqueline Kalms,Helena Wright,(unknown),Frederick W. Muskett,Anthony Scott-Tucker,Andy Merritt,Alistair J. Henry,Alastair D. G. Lawson,(unknown),(unknown),Mark D. Carr	1
4	Design, synthesis, and biological evaluation of novel pyrrolidinone small-molecule Formyl peptide receptor 2 agonists 2021 ·European Journal of Medicinal Chemistry ·(unknown),Almudena Ortega‐Gómez,Sanne L. Maas,José Garrido‐Mesa,Bartolo Ferraro,Mauro Perretti,Andy Merritt,Gerry A. F. Nicolaes,Oliver Soehnlein,Timothy M. Chapman	4
5	Synthesis and evaluation of novel cyclopentane urea FPR2 agonists and their potential application in the treatment of cardiovascular inflammation 2021 ·European Journal of Medicinal Chemistry ·(unknown),Almudena Ortega‐Gómez,Sanne L. Maas,Mauro Perretti,Andy Merritt,Oliver Soehnlein,Timothy M. Chapman	9
6	Fragment-based target screening as an empirical approach to prioritising targets: a case study on antibacterials 2020 ·Drug Discovery Today ·Peter Canning,Kristian Birchall,Catherine Kettleborough,Andy Merritt,P.J. Coombs	7
7	Potent bicyclic inhibitors of malarial cGMP-dependent protein kinase: approaches to combining improvements in cell potency, selectivity and structural novelty 2019 ·Bioorganic & Medicinal Chemistry Letters ·Jonathan M. Large,Kristian Birchall,Nathalie Bouloc,Andy Merritt,(unknown),(unknown),(unknown),Keith H. Ansell,P.J. Coombs,Catherine Kettleborough,David Whalley,Lindsay B. Stewart,Paul W. Bowyer,David A. Baker,Simon A. Osborne	11
8	Developing an Antibody–Drug Conjugate Approach to Selective Inhibition of an Extracellular Protein 2018 ·ChemBioChem ·(unknown),(unknown),(unknown),(unknown),Jonathan M. Large,Seema Patel,David J. Matthews,Andy Merritt	15
9	Trisubstituted thiazoles as potent and selective inhibitors of Plasmodium falciparum protein kinase G (PfPKG) 2018 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Kristian Birchall,Nathalie Bouloc,Jonathan M. Large,Andy Merritt,(unknown),(unknown),Keith H. Ansell,Catherine Kettleborough,David Whalley,Lindsay B. Stewart,Paul W. Bowyer,David A. Baker,Simon A. Osborne	20
10	Design of the LifeArc Index Set and Retrospective Review of Its Performance: A Collection for Sharing 2018 ·SLAS DISCOVERY ·Kristian Birchall,Andy Merritt,(unknown),Catherine Kettleborough,Barbara Saxty	5
11	Potent inhibitors of malarial P. Falciparum protein kinase G: Improving the cell activity of a series of imidazopyridines 2018 ·Bioorganic & Medicinal Chemistry Letters ·Jonathan M. Large,Kristian Birchall,Nathalie Bouloc,Andy Merritt,(unknown),(unknown),(unknown),Keith H. Ansell,P.J. Coombs,Catherine Kettleborough,David Whalley,Lindsay B. Stewart,Paul W. Bowyer,David A. Baker,Simon A. Osborne	14
12	Digoxin reveals a functional connection between HIV-1 integration preference and T-cell activation 2017 ·PLoS Pathogens ·Alexander Zhyvoloup,Anat Melamed,(unknown),Delphine Planas,(unknown),János Kriston-Vizi,Robin Ketteler,Andy Merritt,Jean‐Pierre Routy,Petronela Ancuța,Charles R. M. Bangham,Ariberto Fassati	21
13	Screening β-Arrestin Recruitment for the Identification of Natural Ligands for Orphan G-Protein–Coupled Receptors 2013 ·SLAS DISCOVERY ·C. Southern,Jennifer M. Cook,(unknown),Debra L. Taylor,Catherine Kettleborough,Andy Merritt,Daniel L. Bassoni,William J. Raab,Elizabeth R. Quinn,Tom S. Wehrman,Anthony P. Davenport,Andrew J. Brown,Andrew R. Green,Mark Wigglesworth,Steve Rees	150
14	Fragment-based hit identification: thinking in 3D 2013 ·Drug Discovery Today ·Andrew Morley,Angelo Pugliese,Kristian Birchall,Justin Bower,Paul E. Brennan,Nathan Brown,Tim Chapman,Martin J. Drysdale,Ian H. Gilbert,Swen Hoelder,Allan M. Jordan,Steven V. Ley,Andy Merritt,David S. Miller,Martin E. Swarbrick,Paul G. Wyatt	129
15	A Casein kinase 1/Checkpoint kinase 1 pyrazolo-pyridine protein kinase inhibitor as novel activator of the p53 pathway 2013 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Barbara Saxty,Andy Merritt,Marta Nekulová,Stephen J. Lewis,Yide Huang,Bořivoj Vojtěšek,Catherine Kettleborough,Ted R. Hupp	12
16	Evidence for the Presence of Three Distinct Binding Sites for the Thioflavin T Class of Alzheimer's Disease PET Imaging Agents on β-Amyloid Peptide Fibrils 2004 ·Journal of Biological Chemistry ·Andrew Lockhart,Liang Ye,Duncan B. Judd,Andy Merritt,Peter N. Lowe,(unknown),Guizhu Hong,Antony D. Gee,John Brown	184
17	Combinatorial Approaches to Asymmetric Catalysis. 2003 ·ChemInform ·Andy Merritt	1
18	A practical synthesis of enantiopure (S)-4-(4-hydroxybenzyl)-oxazolidin-2-one 2003 ·Tetrahedron Asymmetry ·Rachel Green,(unknown),Steven D. Bull,Tony D. James,Mary F. Mahon,Andy Merritt	17
19	Combinatorial Library Design and Evaluation: Principles, Software Tools and Applications in Drug Discovery 2002 ·Drug Discovery Today ·Andy Merritt	18
20	Application of High-throughput Screening Techniques to Drug Discovery 2000 ·Progress in medicinal chemistry ·Brian J. Cox,Andy Merritt,(unknown),(unknown),(unknown),Jane Denyer,Brian Evans,Darren V. S. Green,Jane A. Lewis,Martin J. Valler,Steve P. Watson	54

About Andy Merritt

Andy Merritt is a scholar working on Computational Theory and Mathematics, Virology and Pharmacology, having authored 32 papers that have together received 816 indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (10 papers), Microbial Natural Products and Biosynthesis (4 papers) and Asymmetric Synthesis and Catalysis (3 papers). The work is most often cited by research in Computational Theory and Mathematics (172 citations), Organic Chemistry (224 citations) and Molecular Biology (430 citations). Andy Merritt has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Duncan B. Judd, John Brown, Peter N. Lowe, Guizhu Hong, Liang Ye, Andrew Lockhart, Antony D. Gee, Kristian Birchall, Catherine Kettleborough and Elizabeth R. Quinn. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Organic Chemistry and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact